Dexamethasone Sodium Phosphate
Brands: Dmt Suik · Dexamethasone Sodium Phosphate
15 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Brands: Dmt Suik · Dexamethasone Sodium Phosphate
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi, USA LLC | generic | 11 | SUPPLYING |
| Sportpharm LLC | repackager | 4 | SUPPLYING |
| Asclemed USA, Inc. | repackager | 2 | SUPPLYING |
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 2 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 2 | SUPPLYING |
| Mylan Institutional LLC | unknown | 2 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 1 | SUPPLYING |
| Somerset Therapeutics, LLC | generic | 1 | SUPPLYING |
| Henry Schein, Inc. | relabeler | 1 | SUPPLYING |
| Phlow Corporation | unknown | 1 | SUPPLYING |
| Armas Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| Advanced Rx of Tennessee, LLC | repackager | 1 | SUPPLYING |
| Micro Labs Limited | generic | 1 | SUPPLYING |
| A-S Medication Solutions | repackager | 1 | SUPPLYING |
| Cardinal Health 107, LLC | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate. — Recalling firm: SOMERSET THERAPEUTICS LLC — Nationwide in the USA
Dexamethasone Sodium Phosphate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology.